Literature DB >> 12131998

The DOTS strategy in China: results and lessons after 10 years.

Chen Xianyi1, Zhao Fengzeng, Duanmu Hongjin, Wan Liya, Wang Lixia, Du Xin, Daniel P Chin.   

Abstract

OBJECTIVE: To analyse the five-point tuberculosis (TB) strategy, DOTS, 10 years after its implementation in one-half of China's population, and to suggest lessons for future implementation of the DOTS strategy.
METHODS: We analysed trends in case-finding and treatment outcome over time following implementation of the DOTS strategy in each county, using routine reporting data from the Infectious and Endemic Disease Control (IEDC) project (1991 - 2000). We also determined the proportion of counties with different levels of case-finding for the fifth and sixth years of DOTS implementation.
FINDINGS: From 1991 to 1995, DOTS expanded rapidly to cover more than 90% of target population and counties. By 2000, 8 million TB suspects had received free diagnostic evaluation: 1.8 million TB cases were diagnosed, free treatment was provided to 1.3 million smear-positive cases, and more than 90% were cured. During DOTS implementation, the percentage of previously treated cases decreased among all smear-positive cases and treatment outcomes improved. Despite these achievements, the detection rate for new smear-positive cases in the project was estimated to be only 54% in 1998, and 41.2% of the counties had a below average or low level of case-finding (with substantial variation between provinces).
CONCLUSIONS: The IEDC project demonstrated that it is feasible to rapidly expand DOTS on a large scale. The global target of an 85% cure rate was quickly achieved, and the level of drug-resistance was probably reduced by this project. However, case-detection did not reach the 70% global target, and more research is needed on how to enhance this.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12131998      PMCID: PMC2567538     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  23 in total

1.  Patient delay in the diagnosis and treatment of tuberculosis in China: findings of case detection projects.

Authors:  Y Lin; D A Enarson; C-Y Chiang; I D Rusen; L-X Qiu; X-H Kan; Y-L Yuan; J Du; T-H Zhang; Y Li; X-F Li; C-T Du; L-X Zhang
Journal:  Public Health Action       Date:  2015-03-21

2.  Treatment outcomes of pulmonary tuberculosis in the past decade in the mainland of China: a meta-analysis.

Authors:  Xiangwei Li; Yu Yang; Jianmin Liu; Feng Zhou; Wei Cui; Ling Guan; Fei Shen; Cong Gao; Mufei Li; Qi Jin; Lei Gao
Journal:  Front Med       Date:  2013-07-11       Impact factor: 4.592

3.  Expanding tuberculosis case detection by screening household contacts.

Authors:  Mercedes C Becerra; Iliana F Pachao-Torreblanca; Jaime Bayona; Rosa Celi; Sonya S Shin; Jim Yong Kim; Paul E Farmer; Megan Murray
Journal:  Public Health Rep       Date:  2005 May-Jun       Impact factor: 2.792

4.  Mortality and associated risk factors in a cohort of tuberculosis patients treated under DOTS programme in Addis Ababa, Ethiopia.

Authors:  Belete Getahun; Gobena Ameni; Sibhatu Biadgilign; Girmay Medhin
Journal:  BMC Infect Dis       Date:  2011-05-16       Impact factor: 3.090

Review 5.  Prevalence of drug-resistant tuberculosis in mainland China: systematic review and meta-analysis.

Authors:  Yu Yang; Xiangwei Li; Feng Zhou; Qi Jin; Lei Gao
Journal:  PLoS One       Date:  2011-06-03       Impact factor: 3.240

6.  Trends in notifiable infectious diseases in China: implications for surveillance and population health policy.

Authors:  Lei Zhang; David P Wilson
Journal:  PLoS One       Date:  2012-02-16       Impact factor: 3.240

7.  Detection of pulmonary tuberculosis among patients with cough attending outpatient departments in Dar Es Salaam, Tanzania: does duration of cough matter?

Authors:  Esther S Ngadaya; Godfrey S Mfinanga; Eliud R Wandwalo; Odd Morkve
Journal:  BMC Health Serv Res       Date:  2009-07-01       Impact factor: 2.655

8.  Design of the anti-tuberculosis drugs induced adverse reactions in China National Tuberculosis Prevention and Control Scheme Study (ADACS).

Authors:  Yin Yin Xia; Dai Yu Hu; Fei Ying Liu; Xiao Meng Wang; Yan Li Yuan; De Hua Tu; Yi Xin Chen; Lin Zhou; Li Zhen Zhu; Wei Wei Gao; Hong Yuan Wang; Da Fang Chen; Li Yang; Ping Ping He; Xiao Ting Li; Ying Jian He; Feng Sun; Si Yan Zhan
Journal:  BMC Public Health       Date:  2010-05-21       Impact factor: 3.295

9.  Evaluation of the tuberculosis programme in Ningxia Hui Autonomous region, the People's Republic of China: a retrospective case study.

Authors:  Yu Rong Yang; Donald P McManus; Darren J Gray; Xiao Ling Wang; Shu Kun Yang; Allen G Ross; Gail M Williams; Magda K Ellis
Journal:  BMC Public Health       Date:  2012-12-23       Impact factor: 3.295

10.  Treatment outcome of new pulmonary tuberculosis in Guangzhou, China 1993-2002: a register-based cohort study.

Authors:  Qing-Song Bao; Yu-Hua Du; Ci-Yong Lu
Journal:  BMC Public Health       Date:  2007-11-29       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.